Publication | Closed Access

Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers

Histone ModificationsHdac InhibitorsUrologyHistone DeacetylaseGenitourinary CancerOncogenic AgentMedicineCancer GenomicsUrothelial CancersCancer BiologyOncologyRadiation OncologyCancer ResearchTumor Biology